COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,959 Articles (22,604 medRxiv, 8,355 bioRxiv)

Most recent first Previous |  Page 383: Articles 3821-3830  | Next

A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths from COVID-19: a counterfactual study on the impact of the delayed vaccination programme in Iran
Ghafari, M., Hosseinpour, S., Rezaee-Zavareh, M. S., Dascalu, S., Rostamian, S., Aramesh, K., Madani, K., Kordasti, S.
10.1101/2023.05.31.23290799 — Posted: 2023-06-04
Unveiling Womens Experiences Amidst the COVID-19 Pandemic in Nigeria: An Interpretive phenomenological analysis.
Ndu, M., Teachman, G., Martin, J., Nouvet, E.
10.1101/2023.05.30.23290724 — Posted: 2023-06-03
Carotid body dysregulation contributes to the enigma of long COVID
El-Medany, A., Adams, Z. H., Blythe, H. C., Hope, K. A., Kendrick, A. H., Abdala Sheikh, A. P., Paton, J. F., Nightingale, A. K., Hart, E. C.
10.1101/2023.05.25.23290513 — Posted: 2023-06-03
Effectiveness of mRNA-1273 bivalent (Original and Omicron BA.4/BA.5) COVID-19 vaccine in preventing hospitalizations for COVID-19, medically attended SARS-CoV-2 infections, and hospital death in the United States
Tseng, H. F., Ackerson, B. K., Sy, L. S., Tubert, J. E., Luo, Y., Qiu, S., Lee, G. S., Bruxvoort, K. J., Ku, J. H., Florea, A., Takhar, H. S., Bathala, R., Zhou, C. K., Esposito, D., Marks, M. A., Anderson, E. J., Talarico, C. A., Qian, L.
10.1101/2023.05.25.23290456 — Posted: 2023-06-03
Social inequalities in the misbelief of chloroquines protective effect against COVID-19: results from the EPICOVID-19 study in Brazil
Nunes, B., Silva, I. C., Mielke, G. I., Vidaletti, L. P., Silveira, M. F., Hallal, P.
10.1101/2023.05.29.23290677 — Posted: 2023-06-03
Deep Phenotyping of the Lipidomic Response in COVID and non-COVID Sepsis
Meng, H., Sengupta, A., Riccioti, E., Mrcela, A., Mathew, D., Mazaleuskaya, L., Ghosh, S., Brooks, T., Turner, A., Schanoski, A., Lahens, N., Tan, A. W., Woolfork, A., Grant, G., Susztak, K., Letizia, A., Sealfon, S., Wherry, E. J., Laudanski, K., Weljie, A., Meyer, N., Fitzgerald, G.
10.1101/2023.06.02.543298 — Posted: 2023-06-02
Impact of reference design on estimating SARS-CoV-2 lineage abundances from wastewater sequencing data
Assmann, E., Agrawal, S., Orschler, L., Böttcher, S., Lackner, S., Hölzer, M.
10.1101/2023.06.02.543047 — Posted: 2023-06-02
Colocalization of expression transcripts with COVID-19 outcomes is rare across cell states, cell types and organs.
Willett, J. D. S., Lu, T., Nakanishi, T., Yoshiji, S., Butler-Laporte, G., Zhou, S., Farjoun, Y., Richards, J. B.
10.1101/2023.05.29.23290694 — Posted: 2023-06-01
Prevalence of coronary artery disease among COVID-19 patients: a systematic review and meta-analysis
Akhtar, N., Padhi, B. K., Shamin, M. A., Gandhi, N. C., Satapathy, P., Nowrouzi-Kia, B., Shah, R., Rustagi, S., Pati, S., Chattu, V. K.
10.1101/2023.06.01.23290768 — Posted: 2023-06-01
An explanation for SARS-CoV-2 rebound after Paxlovid treatment
Perelson, A. S., Ribeiro, R. M., Phan, T.
10.1101/2023.05.30.23290747 — Posted: 2023-06-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).